Under a consent decree signed Nov. 21, FDA is required to finalize its OTC topical antimicrobial drug products monograph as it applies to triclosan and conform to multiple deadlines over a five-year period in the process to completion.
The decree comes under a settlement of a 2010 lawsuit filed by the National Resources Defense Council against the agency...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?